| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e5c121269689cbab9b3a4548b15caf3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fe9efcec7d9ed77f844ba87d886fb92c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3231 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate |
2012-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa8e6a58966b8679366db00f1860514d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_521a6ec17201dc0e70c7389c7ac96d6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c40ef7c3ca5e7467e2a3e0eef4bee9f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f9a2c76a338497853fd91e1dfaa919a |
| publicationDate |
2013-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2013089157-A1 |
| titleOfInvention |
Oligonucleotide and therapeutic agent for hyperlipidemia containing same as active ingredient |
| abstract |
An oligonucleotide containing a sugar-modified nucleoside is provided, wherein the sugar-modified nucleoside has a cross-linked structure between position 4' and position 2' and the oligonucleotide can bind to an apolipoprotein C-III gene. According to the invention, an oligonucleotide useful as therapeutic agent for hyperlipidemia is obtained, said oligonucleotide having an excellent binding affinity for an apolipoprotein C-III gene, superior stability and is very safe. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020079278-A |
| priorityDate |
2011-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |